| Description |
| Product Type |
Product Size |
| Capsules |
20'S |
| Product Company |
| Brookes Pharmaceutical |
Diclofenac sodium 100mg |
| Product Type |
Product Size |
| Injection
|
6'S |
| Product Company |
| Chiesi Pharmaceuticals |
Meglumine indomethicinate 77.2+50mg
|
| Product Type |
Product Size |
| Tablet |
20'S |
| Product Company |
| Sami Pharmaceutical |
Diclofenac Sodium 50mg |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Pfizer |
Amlodipine besylate 5mg
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Asian Continental |
Diclofenac Sodium 75mg |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Sami Pharmaceutical |
Diclofenac Sodium 100mg |
| Content | The Sustain Release tablet form of diclofenac is used to reduce pain, swelling (inflammation), and joint stiffness from arthritis. | Indomethacin is an anti-inflammatory agent, used to combat pain and inflammation in various conditions
| The enteric-coated tablet form of diclofenac is used to reduce pain, swelling (inflammation), and joint stiffness from arthritis. | Amlodipine is an oral antihypertensive medicine that belongs to the class of calcium channel blockers. It works by relaxing the blood vessels to allow easy flow of blood
| Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).Label NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. | This medicine is used in the management of muscular and skeletal disorder pain, rheumatoid arthritis, osteoarthrosis, ankylosing spondylitis (arthritis affecting joints of spine), acute gout (complex form of arthritis with extreme pain and swelling of joints) and chronic juvenile arthritis (arthritis in children). |
Reviews
There are no reviews yet.